Annual Cash & Cash Equivalents
$24.27 M
+$5.13 M+26.84%
31 December 2023
Summary:
LeMaitre Vascular annual cash & cash equivalents is currently $24.27 million, with the most recent change of +$5.13 million (+26.84%) on 31 December 2023. During the last 3 years, it has fallen by -$2.50 million (-9.32%). LMAT annual cash & cash equivalents is now -11.59% below its all-time high of $27.45 million, reached on 31 December 2015.LMAT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$21.00 M
-$1.27 M-5.69%
30 September 2024
Summary:
LeMaitre Vascular quarterly cash and cash equivalents is currently $21.00 million, with the most recent change of -$1.27 million (-5.69%) on 30 September 2024. Over the past year, it has increased by +$2.95 million (+16.34%). LMAT quarterly cash and cash equivalents is now -44.02% below its all-time high of $37.51 million, reached on 30 September 2017.LMAT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMAT Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +26.8% | +16.3% |
3 y3 years | -9.3% | +20.9% |
5 y5 years | -7.8% | +79.2% |
LMAT Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -9.3% | +75.2% | -21.0% | +51.6% |
5 y | 5 years | -9.3% | +105.9% | -28.3% | +91.9% |
alltime | all time | -11.6% | +7101.5% | -44.0% | +4536.0% |
LeMaitre Vascular Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $21.00 M(-5.7%) |
June 2024 | - | $22.27 M(-16.3%) |
Mar 2024 | - | $26.59 M(+9.6%) |
Dec 2023 | $24.27 M(+26.8%) | $24.27 M(+34.4%) |
Sept 2023 | - | $18.05 M(-7.4%) |
June 2023 | - | $19.49 M(+16.9%) |
Mar 2023 | - | $16.68 M(-12.8%) |
Dec 2022 | $19.13 M(+38.1%) | $19.13 M(+13.1%) |
Sept 2022 | - | $16.91 M(-18.6%) |
June 2022 | - | $20.79 M(+33.6%) |
Mar 2022 | - | $15.56 M(+12.3%) |
Dec 2021 | $13.86 M(-48.2%) | $13.86 M(-20.2%) |
Sept 2021 | - | $17.37 M(-19.4%) |
June 2021 | - | $21.54 M(-8.4%) |
Mar 2021 | - | $23.52 M(-12.1%) |
Dec 2020 | $26.76 M(+127.1%) | $26.76 M(-8.6%) |
Sept 2020 | - | $29.28 M(+46.6%) |
June 2020 | - | $19.98 M(+82.5%) |
Mar 2020 | - | $10.94 M(-7.1%) |
Dec 2019 | $11.79 M(-55.2%) | $11.79 M(+0.6%) |
Sept 2019 | - | $11.72 M(-11.6%) |
June 2019 | - | $13.26 M(-10.2%) |
Mar 2019 | - | $14.77 M(-43.9%) |
Dec 2018 | $26.32 M(+37.8%) | $26.32 M(+30.9%) |
Sept 2018 | - | $20.10 M(+2.4%) |
June 2018 | - | $19.64 M(-13.8%) |
Mar 2018 | - | $22.78 M(+19.3%) |
Dec 2017 | $19.10 M(-21.4%) | $19.10 M(-49.1%) |
Sept 2017 | - | $37.51 M(+24.5%) |
June 2017 | - | $30.12 M(+16.7%) |
Mar 2017 | - | $25.81 M(+6.3%) |
Dec 2016 | $24.29 M(-11.5%) | $24.29 M(-29.9%) |
Sept 2016 | - | $34.65 M(+18.2%) |
June 2016 | - | $29.32 M(+13.0%) |
Mar 2016 | - | $25.94 M(-5.5%) |
Dec 2015 | $27.45 M(+46.9%) | $27.45 M(+16.2%) |
Sept 2015 | - | $23.63 M(+21.6%) |
June 2015 | - | $19.43 M(+14.1%) |
Mar 2015 | - | $17.02 M(-8.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $18.69 M(+27.1%) | $18.69 M(+1.8%) |
Sept 2014 | - | $18.35 M(-21.9%) |
June 2014 | - | $23.51 M(+88.0%) |
Mar 2014 | - | $12.50 M(-15.0%) |
Dec 2013 | $14.71 M(-10.6%) | $14.71 M(+8.0%) |
Sept 2013 | - | $13.63 M(-8.6%) |
June 2013 | - | $14.91 M(-2.6%) |
Mar 2013 | - | $15.30 M(-7.0%) |
Dec 2012 | $16.45 M(-18.3%) | $16.45 M(-20.3%) |
Sept 2012 | - | $20.64 M(+2.4%) |
June 2012 | - | $20.16 M(+2.8%) |
Mar 2012 | - | $19.62 M(-2.5%) |
Dec 2011 | $20.13 M(-11.0%) | $20.13 M(-12.8%) |
Sept 2011 | - | $23.09 M(+7.9%) |
June 2011 | - | $21.41 M(+12.1%) |
Mar 2011 | - | $19.10 M(-15.5%) |
Dec 2010 | $22.61 M(-2.5%) | $22.61 M(-17.6%) |
Sept 2010 | - | $27.45 M(+7.2%) |
June 2010 | - | $25.61 M(+8.2%) |
Mar 2010 | - | $23.66 M(+2.0%) |
Dec 2009 | $23.19 M(+45.9%) | $23.19 M(+17.1%) |
Sept 2009 | - | $19.81 M(+18.3%) |
June 2009 | - | $16.74 M(+18.8%) |
Mar 2009 | - | $14.09 M(-11.3%) |
Dec 2008 | $15.89 M(+148.5%) | $15.89 M(+20.8%) |
Sept 2008 | - | $13.16 M(+23.6%) |
June 2008 | - | $10.65 M(+95.6%) |
Mar 2008 | - | $5.44 M(-14.9%) |
Dec 2007 | $6.40 M(-58.4%) | $6.40 M(-17.5%) |
Sept 2007 | - | $7.75 M(-37.9%) |
June 2007 | - | $12.47 M(-5.8%) |
Mar 2007 | - | $13.24 M(-14.0%) |
Dec 2006 | $15.39 M(+1783.8%) | $15.39 M(+3297.6%) |
Sept 2006 | - | $453.00 K(-32.0%) |
June 2006 | - | $666.00 K(+42.0%) |
Mar 2006 | - | $469.00 K(-42.6%) |
Dec 2005 | $817.00 K(+12.8%) | $817.00 K(+12.8%) |
Dec 2004 | $724.00 K(+114.8%) | $724.00 K |
Dec 2002 | $337.00 K | - |
FAQ
- What is LeMaitre Vascular annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LeMaitre Vascular?
- What is LeMaitre Vascular annual cash & cash equivalents year-on-year change?
- What is LeMaitre Vascular quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly cash and cash equivalents year-on-year change?
What is LeMaitre Vascular annual cash & cash equivalents?
The current annual cash & cash equivalents of LMAT is $24.27 M
What is the all time high annual cash & cash equivalents for LeMaitre Vascular?
LeMaitre Vascular all-time high annual cash & cash equivalents is $27.45 M
What is LeMaitre Vascular annual cash & cash equivalents year-on-year change?
Over the past year, LMAT annual cash & cash equivalents has changed by +$5.13 M (+26.84%)
What is LeMaitre Vascular quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LMAT is $21.00 M
What is the all time high quarterly cash and cash equivalents for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly cash and cash equivalents is $37.51 M
What is LeMaitre Vascular quarterly cash and cash equivalents year-on-year change?
Over the past year, LMAT quarterly cash and cash equivalents has changed by +$2.95 M (+16.34%)